C. Martínez-Campa

发表

Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2016, Cancer letters.

Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2017, International journal of oncology.

Melatonin and Breast Cancer: Selective Estrogen Enzyme Modulator Actions

C. Alonso-González, C. Martínez-Campa, S. Cos, 2013 .

Melatonin and Aromatase in Breast Cancer

C. Alonso-González, C. Martínez-Campa, S. Cos, 2013 .

Melatonin as a selective estrogen enzyme modulator.

C. Alonso-González, C. Martínez-Campa, S. Cos, 2008, Current cancer drug targets.

Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats.

C. Alonso-González, C. Martínez-Campa, S. Cos, 2007, Maturitas.

Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2006, Cancer detection and prevention.

The hexokinase 2 protein participates in regulatory DNA‐protein complexes necessary for glucose repression of the SUC2 gene in Saccharomyces cerevisiae

C. Martínez-Campa, P. Herrero, F. Moreno, 1998, FEBS letters.

Melatonin inhibits both ERα activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium

C. Alonso-González, C. Martínez-Campa, S. Cos, 2006, Journal of pineal research.

Melatonin, an Endogenous-specific Inhibitor of Estrogen Receptor α via Calmodulin*

C. Martínez-Campa, B. del Rio, P. S. Lazo, 2004, Journal of Biological Chemistry.

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2010, Current cancer drug targets.

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells

C. Alonso-González, Alicia González, C. Martínez-Campa, 2005, Breast Cancer Research and Treatment.

Melatonin modulates aromatase activity in MCF‐7 human breast cancer cells

C. Martínez-Campa, S. Cos, E. Sánchez-Barceló, 2005, Journal of pineal research.

Melatonin inhibits the growth of DMBA‐induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity

C. Alonso-González, Alicia González, C. Martínez-Campa, 2006, International journal of cancer.

Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2008, Cancer letters.

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

C. Alonso-González, C. Martínez-Campa, S. Cos, 2009, British Journal of Cancer.

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2006, Cancer letters.

Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments

C. Alonso-González, C. Martínez-Campa, Javier Menéndez-Menéndez, 2021, Cancers.

Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells

C. Alonso-González, C. Martínez-Campa, S. Cos, 2007, British Journal of Cancer.

Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process

C. Alonso-González, Alicia González, C. Martínez-Campa, 2020, Scientific Reports.

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells

C. Alonso-González, Alicia González, C. Martínez-Campa, 2008, Journal of pineal research.

Characterization of HSP27 phosphorylation induced by microtubule interfering agents: implication of p38 signalling pathway.

C. Martínez-Campa, J. Iglesias, Miguel A. Prado, 2007, Archives of biochemistry and biophysics.

The Naturally Occurring Variant of Estrogen Receptor (ER) ERΔE7 Suppresses Estrogen-Dependent Transcriptional Activation by Both Wild-Type ERα and ERβ

C. Martínez-Campa, P. S. Lazo, S. Ramos, 2003 .

Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2017, Oncology reports.

Abnormal Properties of Mutants in the Hinge Region of ERα: Implications in Breast Cancer

C. Martínez-Campa, P. Casado, J. García-Pedrero, 2005 .

Calmodulin is a selective modulator of estrogen receptors.

C. Martínez-Campa, M. Muramatsu, B. del Rio, 2002, Molecular endocrinology.

Molecular analysis of the promoter region of the hexokinase 2 gene of Saccharomyces cerevisiae.

C. Martínez-Campa, P. Herrero, F. Moreno, 1996, FEMS microbiology letters.

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa).

C. Alonso-González, Alicia González, C. Martínez-Campa, 2008, Toxicology letters.

Melatonin prevents the estrogenic effects of sub‐chronic administration of cadmium on mice mammary glands and uterus

C. Alonso-González, C. Martínez-Campa, S. Cos, 2007, Journal of pineal research.

Transcriptional regulation of the Saccharomyces cerevisiae HXK1, HXK2 and GLK1 genes

C. Martínez-Campa, P. Herrero, F. Moreno, 1995, Yeast.

The Naturally Occurring Variant of Estrogen Receptor (ER) ER (cid:1) E7 Suppresses Estrogen-Dependent Transcriptional Activation by Both Wild-Type ER (cid:2) and ER (cid:3)

C. Martínez-Campa, P. S. Lazo, S. Ramos, 2003 .

Vincristine regulates the phosphorylation of the antiapoptotic protein HSP27 in breast cancer cells.

C. Martínez-Campa, P. Casado, E. D. del Valle, 2007, Cancer letters.

Melatonin promotes differentiation of 3T3‐L1 fibroblasts

C. Alonso-González, Alicia González, C. Martínez-Campa, 2012, Journal of pineal research.

Identification and characterisation of two transcriptional repressor elements within the coding sequence of the Saccharomyces cerevisiae HXK 2 gene

C. Martínez-Campa, P. Herrero, F. Moreno, 1996 .

Melatonin affects the dynamic steady-state equilibrium of estrogen sulfates in human umbilical vein endothelial cells by regulating the balance between estrogen sulfatase and sulfotransferase.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2015, International journal of molecular medicine.

Melatonin Modulation of Radiation-Induced Molecular Changes in MCF-7 Human Breast Cancer Cells

C. Alonso-González, C. Martínez-Campa, Javier Menéndez-Menéndez, 2022, Biomedicines.

Melatonin modulates aromatase activity and expression in endothelial cells.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2013, Oncology reports.

Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2017, Oncology reports.

Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers

C. Martínez-Campa, Javier Menéndez-Menéndez, 2018, International journal of endocrinology.

Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin

C. Alonso-González, Alicia González, C. Martínez-Campa, 2019, Cancers.

Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double‐strand DNA break repair

C. Alonso-González, Alicia González, C. Martínez-Campa, 2015, Journal of pineal research.

Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.

S. Hill, C. Alonso-González, C. Martínez-Campa, 2007, Oncology reports.

Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts

C. Alonso-González, Alicia González, C. Martínez-Campa, 2019, International journal of molecular sciences.

Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)

C. Alonso-González, Alicia González, C. Martínez-Campa, 2014, Oncology letters.

Melatonin modulation of cross talk among malignant epithelial , endothelial and adipose cells in breast cancer ( Review )

C. Alonso-González, Alicia González, C. Martínez-Campa, 2014 .

Melatonin as a Radio-Sensitizer in Cancer

C. Alonso-González, Alicia González, C. Martínez-Campa, 2020, Biomedicines.

Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells

C. Alonso-González, Alicia González, C. Martínez-Campa, 2013, Journal of pineal research.

What is known about melatonin, chemotherapy and altered gene expression in breast cancer

C. Alonso-González, Alicia González, C. Martínez-Campa, 2017, Oncology letters.

Antiangiogenic effects of melatonin in endothelial cell cultures.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2013, Microvascular research.

Precise nucleosome positioning and the TATA box dictate requirements for the histone H4 tail and the bromodomain factor Bdf1.

J. Mellor, C. Martínez-Campa, J. Moreau, 2004, Molecular cell.

Melatonin–estrogen interactions in breast cancer

C. Alonso-González, Alicia González, C. Martínez-Campa, 2005, Journal of pineal research.

Rapid isolation of yeast plasmids as native chromatin.

J. Mellor, C. Martínez-Campa, N. Kent, 1997, Nucleic acids research.

Effect of Vinca alkaloids on ERα levels and Estradiol-induced responses in MCF-7 cells

C. Martínez-Campa, P. Casado, J. García-Pedrero, 2006, Breast Cancer Research and Treatment.

Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin.

C. Martínez-Campa, B. del Rio, Beatriz del Río, 2004, The Journal of biological chemistry.

Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process

C. Alonso-González, Alicia González, C. Martínez-Campa, 2019, Front. Physiol..

Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production

C. Alonso-González, Alicia González, C. Martínez-Campa, 2012, Journal of pineal research.

Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process

C. Alonso-González, Alicia González, C. Martínez-Campa, 2020, Scientific Reports.

New Insights in Radiotherapy

C. Martínez-Campa, 2022, Biomedicines.

Editorial for the Special Issue “New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies”

C. Alonso-González, C. Martínez-Campa, 2020, International journal of molecular sciences.

Effects of MT 1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells

S. Hill, C. Alonso-González, C. Martínez-Campa, 2022 .

Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2017, Oncology reports.

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells

C. Alonso-González, C. Martínez-Campa, S. Cos, 2008, Journal of pineal research.

Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.

C. Alonso-González, Alicia González, C. Martínez-Campa, 2010, Oncology reports.